[1] INSPIRIS RESILIA:主动脉瓣膜,适用于天然或人工主动脉心脏瓣膜的置换,注册证编号:国械注进20203130521 [2] Bavaria J E , Griffith B , Heimansohn D A , et al. Five-year Outcomes of the COMMENCE Trial Investigating Aorti...
Methods: All adult patients undergoing aortic valve replacement in the last 12 months were enrolled (182 patients receiving PM-EASE, 39 receiving IR). Baseline and operative variables, hospital outcome and echocardiographic data (preoperative, discharge, 3 months, 6 months, and 1 year) were ...
[1] INSPIRIS RESILIA:主动脉瓣膜,适用于天然或人工主动脉心脏瓣膜的置换,注册证编号:国械注进20203130521。 [2] Griffith, et al. Four-year Outcomes of Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. Ameri...
[1] INSPIRIS RESILIA:主动脉瓣膜,适用于天然或人工主动脉心脏瓣膜的置换,注册证编号:国械注进20203130521 [2] Bavaria J E , Griffith B , Heimansohn D A , et al. Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement with RESILIA Tissue. 2022....
[2]Griffith, et al. Four-year Outcomes of Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. American Association for Thoracic Surgery, 2019 Annual Meeting.
Objective: Mechanical aortic valve replacement (AVR) is still the recommended valve substitute in young adults, although cultural reasons have popularized bioprostheses also in these patients. Indeed, structural valve deterioration (SVD) is still the major concern of bioprosthesis in young adults. ...
Surgical aortic valve replacementINSPIRIS RESILIAMagna EasePatient–prosthesis mismatchStructural valve deteriorationTransvalvular gradientOBJECTIVES The INSPIRIS aortic valve combines the RESILIA proprietary tissue preservation process and an expandable stent frame to benefit future transcatheter valve-in-valve ...
Preliminary Experience with Edwards INSPIRIS RESILIA® Compared with Carpentier-Edwards PERIMOUNT MAGNA EASE® for Aortic Valve Replacement: A Propensity-score Matched Pilot StudyIlaria FranzeseAlessandra FrancicaIlaria TropeaFilippo TonelliLivio San Biagio...
In recent years, the increasing use of biological prostheses for surgical aortic valve replacement (AVR), has led to the development of new devices with improved hemodynamics and expected durability.#In this observational retrospective two-center cohort study, two innovative bioprostheses, INSPIRIS ...
[2]Griffith, et al. Four-year Outcomes of Aortic Valve Replacement with a Bioprosthetic Valve with a Novel Tissue. American Association for Thoracic Surgery, 2019 Annual Meeting. 本文内容为《门诊》杂志原创内容 转载须经授权并...